Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589798814> ?p ?o ?g. }
- W2589798814 endingPage "2551" @default.
- W2589798814 startingPage "2526" @default.
- W2589798814 abstract "In order to develop novel κ agonists restricted to the periphery, a diastereo- and enantioselective synthesis of (4aR,5S,8aS)-configured decahydroquinoxalines 5–8 was developed. Physicochemical and pharmacological properties were fine-tuned by structural modifications in the arylacetamide and amine part of the pharmacophore as well as in the amine part outside the pharmacophore. The decahydroquinoxalines 5–8 show single-digit nanomolar to subnanomolar κ-opioid receptor affinity, full κ agonistic activity in the [35S]GTPγS assay, and high selectivity over μ, δ, σ1, and σ2 receptors as well as the PCP binding site of the NMDA receptor. Several analogues were selective for the periphery. The anti-inflammatory activity of 5–8 after topical application was investigated in two mouse models of dermatitis. The methanesulfonamide 8a containing the (S)-configured hydroxypyrrolidine ring was identified as a potent (Ki = 0.63 nM) and highly selective κ agonist (EC50 = 1.8 nM) selective for the periphery with dose-dependent anti-inflammatory activity in acute and chronic skin inflammation." @default.
- W2589798814 created "2017-03-03" @default.
- W2589798814 creator A5000856539 @default.
- W2589798814 creator A5002640669 @default.
- W2589798814 creator A5012301148 @default.
- W2589798814 creator A5013120423 @default.
- W2589798814 creator A5015679062 @default.
- W2589798814 creator A5019059001 @default.
- W2589798814 creator A5020525513 @default.
- W2589798814 creator A5022516580 @default.
- W2589798814 creator A5029626784 @default.
- W2589798814 creator A5036164605 @default.
- W2589798814 creator A5039361070 @default.
- W2589798814 creator A5040260186 @default.
- W2589798814 creator A5040944382 @default.
- W2589798814 creator A5043560865 @default.
- W2589798814 creator A5047067760 @default.
- W2589798814 creator A5051340011 @default.
- W2589798814 creator A5058346757 @default.
- W2589798814 creator A5058633327 @default.
- W2589798814 creator A5061053817 @default.
- W2589798814 creator A5066788016 @default.
- W2589798814 creator A5082994260 @default.
- W2589798814 creator A5087159924 @default.
- W2589798814 creator A5088271343 @default.
- W2589798814 date "2017-03-13" @default.
- W2589798814 modified "2023-10-09" @default.
- W2589798814 title "Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity<i>in Vivo</i>" @default.
- W2589798814 cites W1515847803 @default.
- W2589798814 cites W1561210178 @default.
- W2589798814 cites W1775629781 @default.
- W2589798814 cites W1950271935 @default.
- W2589798814 cites W1970316838 @default.
- W2589798814 cites W1971805652 @default.
- W2589798814 cites W1975900450 @default.
- W2589798814 cites W1979636020 @default.
- W2589798814 cites W1983843154 @default.
- W2589798814 cites W1987936533 @default.
- W2589798814 cites W1994519417 @default.
- W2589798814 cites W1996025792 @default.
- W2589798814 cites W1999561809 @default.
- W2589798814 cites W2003394377 @default.
- W2589798814 cites W2005310645 @default.
- W2589798814 cites W2008975540 @default.
- W2589798814 cites W2009929465 @default.
- W2589798814 cites W2010998976 @default.
- W2589798814 cites W2011802953 @default.
- W2589798814 cites W2012687761 @default.
- W2589798814 cites W2013812716 @default.
- W2589798814 cites W2014290968 @default.
- W2589798814 cites W2014554266 @default.
- W2589798814 cites W2020577176 @default.
- W2589798814 cites W2023950090 @default.
- W2589798814 cites W2025006912 @default.
- W2589798814 cites W2031678191 @default.
- W2589798814 cites W2038041171 @default.
- W2589798814 cites W2039990838 @default.
- W2589798814 cites W2047405674 @default.
- W2589798814 cites W2047577743 @default.
- W2589798814 cites W2051690250 @default.
- W2589798814 cites W2054305392 @default.
- W2589798814 cites W2058633866 @default.
- W2589798814 cites W2059639341 @default.
- W2589798814 cites W2060109352 @default.
- W2589798814 cites W2061144321 @default.
- W2589798814 cites W2066978492 @default.
- W2589798814 cites W2068879317 @default.
- W2589798814 cites W2072332367 @default.
- W2589798814 cites W2074631079 @default.
- W2589798814 cites W2076041228 @default.
- W2589798814 cites W2081338081 @default.
- W2589798814 cites W2081889709 @default.
- W2589798814 cites W2082873584 @default.
- W2589798814 cites W2084910781 @default.
- W2589798814 cites W2087623596 @default.
- W2589798814 cites W2093608501 @default.
- W2589798814 cites W2099632253 @default.
- W2589798814 cites W2107453847 @default.
- W2589798814 cites W2110566477 @default.
- W2589798814 cites W2116103080 @default.
- W2589798814 cites W2124702146 @default.
- W2589798814 cites W2133960827 @default.
- W2589798814 cites W2149501066 @default.
- W2589798814 cites W2185095623 @default.
- W2589798814 cites W2239384431 @default.
- W2589798814 cites W2316615253 @default.
- W2589798814 cites W2323301233 @default.
- W2589798814 cites W2324507733 @default.
- W2589798814 cites W2324711252 @default.
- W2589798814 cites W2346407684 @default.
- W2589798814 cites W2398639618 @default.
- W2589798814 cites W2518740409 @default.
- W2589798814 cites W2950316963 @default.
- W2589798814 cites W2951671798 @default.
- W2589798814 cites W3022814909 @default.
- W2589798814 cites W4238102997 @default.
- W2589798814 cites W4253736942 @default.
- W2589798814 cites W4293247451 @default.